---
schema_version: "secwatch.filing_event.v1"
accession: "0001662774-24-000013"
form_type: "8-K"
ticker: "QNCX"
cik: "0001662774"
company_name: "Quince Therapeutics, Inc."
filed_at: "2024-11-14T23:59:59+00:00"
generated_at: "2026-05-30T00:30:35.079665+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Quince Therapeutics regains Nasdaq minimum bid price compliance; delisting risk removed

## Summary
- On Nov 12, 2024, Nasdaq confirmed Quince regained compliance with $1.00 minimum bid price rule.
- Compliance achieved after closing bid price stayed at or above $1.00 for 10 consecutive business days (Oct 29–Nov 11, 2024).
- This resolves the non-compliance notice received June 20, 2024, and the matter is closed.
- The company was facing potential delisting from Nasdaq Global Select Market if not compliant by Dec 17, 2024.

## SEC filing metadata
- accession: 0001662774-24-000013
- form_type: 8-K
- ticker: QNCX
- cik: 0001662774
- company_name: Quince Therapeutics, Inc.
- filed_at: 2024-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1662774/000166277424000013/0001662774-24-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1662774/000166277424000013/qncx-20241112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001662774-24-000013
- JSON: https://secwatch.observer/filing/0001662774-24-000013.json
- Plain text: https://secwatch.observer/filing/0001662774-24-000013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.